Patent 7070993 was granted and assigned to Novartis on July, 2006 by the United States Patent and Trademark Office.
The present invention provides novel lentiviral packaging constructs that are useful for the establishment of stable packaging cell lines and producer cell lines. In particular, the present invention provides novel packaging cell lines that are capable of constitutively expressing high levels of lentiviral proteins.